Adiponectin and development of type 2 diabetes in the Pima Indian population
Robert S. Lindsay(National Institutes of Health), Jonathan Krakoff(National Institute of Diabetes and Digestive and Kidney Diseases), William C. Knowler(George Washington University), Sachiyo Tanaka(Osaka University), Yūji Matsuzawa(Sumitomo Hospital), Tohru Funahashi(The University of Osaka), P. Antonio Tataranni(National Institutes of Health), Robert L. Hanson(National Institute of Diabetes and Digestive and Kidney Diseases)
Cited by 1,103
Related Papers
Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia
|The Journal of Clinical Endocrinology & Metabolism|2001|3.4k
Circulating Ghrelin Levels Are Decreased in Human Obesity
|Diabetes|2001|2k
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
|Diabetes Care|2007|1.5k
Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts Type II diabetes independent of insulin resistance
|Diabetologia|2000|791
Adiponectin, Metabolic Risk Factors, and Cardiovascular Events among Patients with End-Stage Renal Disease
|Journal of the American Society of Nephrology|2002|761